Successful switch from enzyme replacement therapy to miglustat in an adult patient with type 1 Gaucher disease: a case report

BACKGROUND: Gaucher disease is one of the most common lipid-storage disorders, affecting approximately 1 in 75,000 births. Enzyme replacement therapy with recombinant glucocerebrosidase is currently considered the first-line treatment choice for patients with symptomatic Gaucher disease type 1. Oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Giuffrida, Gaetano, Lombardo, Rita, Di Francesco, Ernesto, Parrinello, Laura, Di Raimondo, Francesco, Fiumara, Agata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100336/
https://www.ncbi.nlm.nih.gov/pubmed/27821156
http://dx.doi.org/10.1186/s13256-016-1060-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100336/
https://www.ncbi.nlm.nih.gov/pubmed/27821156
http://dx.doi.org/10.1186/s13256-016-1060-y

Ejemplares similares